Vancouver, BC – May 4th, 2021– AbCellera (Nasdaq: ABCL) today announced that a second antibody from its collaboration with Eli Lilly and Company (Lilly), LY-CoV1404, has entered clinical trials in… Read More
Zymeworks recently received clearance from the FDA for its first randomized Phase 3 clinical trial for zanidatamab. HERIZON-GEA-01 is a randomized, multicenter study of zanidatamab in combination with chemotherapy with… Read More
Meet ‘Ready-to-Raise’ ventures, from our later stage incubator and HATCH Accelerator, at our upcoming 2021 Investor Showcase! The Investor Showcase spotlights high-potential, investible ventures currently supported through entrepreneurship@UBC and the… Read More
Patents granted in the United States, China, South Korea, Japan, Israel and New Zealand for dermal injector and tendon regeneration technologies VANCOUVER, BC – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV:… Read More
CSPC is excited to announce the themes and topics for the 13th Canadian Science Policy Conference! As Canada focuses on the future and post-pandemic rebuilding process, the overarching message of… Read More
